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ABSTRACT 
 
Eradication of ovine Johne’s disease requires destocking sheep and spelling land until 
Mycobacterium avium subsp. paratuberculoisis has died out. There is no simple way to 
assess the residual level of contamination or the risk this poses to livestock. Consequently 
small groups of Merino weaners were orally dosed with M. avium subsp. paratuberculosis.  
Within 7-14 weeks the organism could be cultured from various locations in the 
gastrointestinal tract and associated lymph nodes. In addition, the results of a skin test were 
positive in 66% of weaners in which the organism had established an infection and were 
negative in uninfected sheep. The results of tests for gamma interferon  were positive in 
some infected weaners but also in some of the controls. An ELISA test was not  useful at this 
early stage of infection. Overall, the results suggest that weaner sheep could be used as 
sentinels in an infected environment, but this requires validation in a controlled field trial. 
Furthermore, the results suggest that the infectious dose of M. avium subsp. 
paratuberculosis may be higher than previously thought.  
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EXECUTIVE SUMMARY 
 
Eradication of ovine Johne’s disease requires destocking sheep and spelling land until 
Mycobacterium avium subsp. paratuberculoisis has died out. At the conclusion of a 
decontamination period, currently deemed to be 2 consecutive summers or 15 months, there 
is no simple way to assess either the residual level of contamination of the environment or 
the risk residual contamination poses to livestock.  
 
This study was undertaken to determine whether it is possible to detect infection in young 
sheep exposed to low levels of contamination. Previous experiments in the United Kingdom 
suggested that this might be possible, but the trials had been done with cattle strains of M. 
avium subsp. paratuberculosis. Consequently in this project small groups of Merino weaners 
were orally dosed on repeated occasions with graded numbers of an Australian sheep strain 
of  M. avium subsp. paratuberculosis.  Samples were collected from each weaner at regular 
intervals and evaluated using several tests. 
 
Within 7 to14 weeks the organism could be cultured from various locations in the 
gastrointestinal tract and associated lymph nodes of each sheep that was given a total dose 
of 1.3 to 6.9 x 107 organisms.  Infection was not established in weaners given lower doses. 
The next lower dose was 8.2 x 103 . Therefore the infectious dose of this strain of M. avium 
subsp. paratuberculosis is somewhere between  about  103  and 107 organisms, a value 
higher than that found in the UK experiments.  Reevaluation of the methods used in the UK 
experiments suggest that the doses given may have been underestimated by a wide margin.  
Thus the present results suggest that the infectious dose of M. avium subsp. 
paratuberculosis may be higher than previously thought with the implication that it may be 
possible to reduce decontamination periods for land. In other words it might be easier to 
achieve decontamination of land than previously imagined. 
 
Although infection was found by culture of tissues of these weaners, there would be a need 
to culture all sentinel sheep unless an indirect method could be found to identify sheep most 
likely to be culture positive. Fortunately the results of a skin test were positive in 66% of 
weaners in which the organism had established an infection and were negative in uninfected 
sheep, regardless of whether they had been dosed with the organism or were in a control 
group. The results of tests for gamma interferon  were positive in some infected weaners but 
also in some of the controls so this test was not of value. An ELISA test also was not useful 
at this early stage of infection. Overall, the results suggest that weaner sheep could be used 
as sentinels in an infected environment, and that the skin test could be used to select 
individual sentinel sheep for culture. This approach requires validation in a controlled field 
trial.  
 
The experimental infection method developed in this study can be used later for other 
purposes such as evaluating the pathogenesis of ovine Johne’s disease, the behaviour of 
new diagnostic tests and vaccine efficacy.  
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1. MAIN RESEARCH REPORT 
 
1.1 Background and industry context 
 
Each of the livestock industries in Australia has addressed or is addressing a control 
program for Johne’s disease. The reason for this is the need to reduce actual or perceived 
impacts from this disease, which include production losses and trade restrictions, nationally 
and internationally. 
 
Eradication of ovine Johne’s disease requires destocking sheep and spelling land until 
Mycobacterium avium subsp. paratuberculoisis has died out. At the conclusion of a 
decontamination period, currently deemed to be 2 consecutive summers or 15 months, there 
is no simple way to assess either the residual level of contamination of the environment or 
the risk residual contamination poses to livestock. Work is underway to measure the duration 
of survival of the organism in soil in experimental plots but these studies will not determine 
whether infectious doses of the organism remain or whether these viable organisms are 
available to sheep. For example they might be caught in the soil profile and might pose no 
risk. 
 
For the above reasons it was thought necessary to develop an infection model that uses live 
sheep. Such an approach is used in other disease control or monitoring programs, 
particularly for viral diseases, and the animals involved are known as tracers or sentinel 
livestock.  The tracers or sentinels provide an early warning that an infectious disease is 
present or active.  
 
Johne’s disease differs from most other infectious diseases of farm livestock because the 
incubation period, or time elapsing between infection and signs of sickness, is measured in 
years not days or weeks. This is a major disadvantage for use of tracer animals. There is a 
need to find a way of detecting the infection soon after it has occurred. The tracer weaner 
pilot study described in this report was undertaken for this reason. 
 
1.2 Project Objectives 
 
To show that Australian ovine M. avium subsp.  paratuberculosis isolates are capable of 
colonising the intestines of newly weaned merino lambs after oral dosing at levels likely to be 
representative of those in the field, and that M. avium subsp.  paratuberculosis can be 
detected in these lambs four to six weeks after dosing. 
 
To develop an experimental system for M. avium subsp.  paratuberculosis infection, 
providing a tool for further work on pathogenesis and early diagnostic tests. 
 
1.3 Introduction 
 
Work by Brotherston et al in the UK in the 1960’s using Cheviot sheep as an experimental 
model  for bovine Johnes disease demonstrated that single or multiple oral doses from 103 to 
109  viable Mycobacterium avium subsp. paratuberculosis) could produce detectable infection 
in intestines and mesenteric lymph nodes of most inoculated sheep as early as four weeks 
after the last dose. Significantly, this was many months to years before the likely 
development of clinical disease. We sought to investigate whether this early detection of M. 
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avium subsp. paratuberculosis could be utilised to determine the infectivity of pasture 
following removal of infected sheep, using “tracer-weaner” lambs as “vacuum cleaners” to 
pick up organisms from pasture. Our study was a pilot pen trial under controlled conditions. 
 
In particular we sought to demonstrate that Australian ovine M. avium subsp. 
paratuberculosis isolates are capable of colonising the intestines of recently weaned merino 
lambs after oral dosing at levels likely to be encountered during natural infection, and that the 
organism can be detected in these lambs four to six weeks later. This work would also 
provide an experimental system for M. avium subsp. paratuberculosis infection, facilitating 
further work on pathogenesis, early diagnostic tests and vaccines (Trials 1.6 - 1.7). 
 
1.4 Methods 
 
1.4.1 Animals 
 
40 Merino lambs (12-16 wk old) from the EMAI flock (tested negative for Johne’s disease by 
serology and faecal culture) were weaned onto wire in the EMAI medium security animal 
house,  drenched for internal parasites with Ivomec and Seponver and fed sheep pellets 
(mainly lucerne in composition) ad-lib. One week before inoculation (2/2/99) they were 
allocated randomly into groups as detailed in Table 1. All groups were held separately; 
different dose groups were housed in different rooms, and groups of sheep with different 
schedules of the same dose were separated by double weldmesh partitions in the same 
room. Any intervention (eg routine cleaning, sampling or dosing) was done in order: control 
then  low then medium then high dose groups. Disinfectant footbaths were used on exit from 
each room, operators wore disposable plastic coveralls and all effluent was heat-treated at 
70 oC for one hour. Lambs were euthanased with IV barbiturate  5 weeks after the last dose. 
 
1.4.2 Inoculae 
 
M. avium subsp. paratuberculosis was isolated from six separate faecal samples collected 
from sheep from a known infected farm in modified Bactec medium 1, sub-cultured onto 
slopes of modified Middlebrook 7H10 medium and its identity verified by IS900 and IS1311 
PCR with REA 2 3. Colonies were harvested into phosphate buffered saline (PBS) from these 
slopes, suspended, pooled and used to inoculate another Bactec vial which was used as 
stock culture. Subcultures into fresh Bactec vials were made from this vial when required. 
These were then subcultured after 3-4 weeks onto modified 7H10 slopes. Colonies from six 
6-week-old slopes with confluent growth were harvested into a total volume of 1ml PBS. This 
was termed “neat suspension”, some of which was used immediately, and the remainder 
stored at 4 oC until used. Three separate neat suspension preparations were used, one for 
inoculations at weeks 0, 1 and 2, the second for weeks 3, 4 and 5, and the third for weeks 6 
to 9. The total number of M. avium subsp. paratuberculosis (viable and non-viable) in the 
suspensions was determined by direct counts of appropriate dilutions in a Thoma counting 
chamber. Based on previous experiments the numbers of viable M. avium subsp. 
paratuberculosis were estimated to be 0.5 to 1 log lower than the direct count. Neat 
suspension was diluted in PBS immediately before each inoculation to provide the intended 
dose for each lamb (see Table 1) in a volume of 2 ml, which was delivered to the back of the 
pharynx using a syringe with bulb-ended needle. The actual dose in terms of viable 
organisms was determined retrospectively from the neat suspensions by culture in modified 
Bactec media using replicate serial dilutions to provide most probable number (MPN) 
estimates. Briefly, for each MPN estimate five 0.1 ml replicates of each of seven serial 
tenfold dilutions were inoculated into Bactec vials, and growth indices measured weekly. The 
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MPN estimates were read from published tables 4 using the culture results (number of 
positive samples from the five replicate vials) for three appropriate sequential dilutions. 
Because there may be loss of viability of M. avium subsp. paratuberculosis during storage at 
4 oC, viable estimates were repeated at weeks 2, 5 and 9 for each suspension respectively 
and the average number of viable organisms in each dose was determined. Thus an MPN 
estimate was made for each time point when inoculation of lambs was conducted. 
 
1.4.3 Clinical and necropsy sampling 
 
Lambs were sampled immediately before the first dose, fortnightly thereafter and on the day 
of necropsy (see Table 1). One faecal pellet was collected manually from the rectum of each 
lamb at each sampling time. Blood was collected from the jugular vein into plain and lithium 
heparin vacutainers. In addition, faecal samples were collected daily from the high and 
medium dose groups in the extended dose regime. At necropsy a range of tissues (caecum, 
colon, , ileocaecal valve, terminal ileum x 4, jejunum - with and without Peyers patches,  
duodenum, ileocaecal node, caudal mesenteric node, two more mesenteric nodes, 
retropharangeal node and pharangeal tonsil) were collected for M. avium subsp. 
paratuberculosis isolation. The same range of tissues was also collected into 10% neutral 
buffered formalin for histopathology. In addition duplicate samples were collected from the 
above range of tissues, plus a further 35 sites, and stored at -80 oC, pending further 
investigation (Appendix 6). 
 
1.4.4 Serology for antibodies to M avium subsp. paratuberculosis 
 
Plain blood samples were allowed to clot and retract, and serum was removed and stored at 
-20 oC for up to 4 months until assayed using a commercial kit (PARACHEK Johne’s 
absorbed EIA, CSL, Parkville, Victoria) according to manufacturer’s instructions. 
 
1.4.5 Gamma interferon assay 
 
Lithium heparin blood samples were assayed for gamma interferon (IFN-γ) using a 
commercial test kit (Bovigam, Bovine gamma interferon test, CSL, Parkville, Victoria) 
according to manufacturer’s recommendations but with slight modifications. The kit was 
developed for use with cattle. Briefly, three 1.5 ml aliquots of well mixed heparinised blood 
were incubated for 18 hours at 37 oC in eppendorf tubes with 100 µl of bovine PPD, avian 
PPD (both 300 µl/ml) and PBS, respectively. Plasma was collected after centrifugation at 500 
g for 10 minutes, and stored frozen at -20 oC for up to five months. Samples were thawed 
overnight at 4 oC, allowed to equilibrate to room temperature and thoroughly mixed by 
vortexing before use in the enzyme immunoassay (EIA). The EIA was performed exactly 
according to the manufacturer’s recommendations. Briefly, samples were added to 96 well 
microtitre plates coated with antibody to bovine IFN-γ, incubated and washed. Conjugate 
(horseradish peroxidase labelled anti-bovine IFN-γ) was added, incubated and washed. 
Enzyme substrate was added, incubated, the reaction was stopped and absorbance was 
read at 450 nm. Sera were again frozen at -20 oC for a further 4 months and the EIA was the 
repeated after centrifugation of the thawed plasma samples to remove any clots which had 
formed. 
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1.4.6 Interadermal testing for delayed type hypersensitivity 
 
One week before euthanasia lambs were injected intradermally on the wool-free inner 
thigh/inguinal region with 0.1 ml Johnin PPD (0.5 mg/mL, CSL, Parkville, Victoria). Skin 
thickness was measured with vernier callipers before injection and 72 hours later. 
 
1.4.7 M. avium subsp. Paratuberculosis isolation 
 
The samples collected fortnightly and at necropsy were processed on the day of collection. 
Additional daily faecal samples were frozen at -80 oC for up to 5 months until processed. 
Faecal samples were prepared by the double incubation method of Whitlock and 
Rosenberger 5. Briefly, the faecal pellet was placed in a 15 ml polypropylene tube and broken 
up in 10-12 ml of sterile normal saline using a swab stick. After mixing, the tube was allowed 
to stand for 30 min at room temperature. A 5ml aliquot of the surface fluid was transferred to 
a 35ml polystrene tube containing 25ml of 0.9% hexadecylpyridinium chloride (HPC) (Sigma 
Chemical Co., St Louis, Mo) in half-strength brain heart infusion broth (Oxoid, Basingstoke, 
England) and allowed to stand at 37 oC for 24 h. The tube was centrifuged at 900 g for 30 
mins. The pellet was resuspended in 1 ml sterile water with vancomycin (100 µg/ml), nalidixic 
acid (100 µg/ml) and amphoteracin B (50 µg/ml) (all Sigma) and incubated for 48 to 72 h at 
37 oC. 0.1ml was then inoculated into Bactec vials. Tissue samples (approximately 1-5 g) 
were trimmed of fat and fibrous tissue and homogenised for 30 s in 2 ml sterile normal saline 
in a blender. After adding 25 ml 0.75% HPC, the homogenates were left standing at room 
temperature for 72 h and 0.1 ml of sediment was collected carefully from the bottom of the 
tube for inoculation into Bactec vials. The modified Bactec 12B radiometric medium 
consisted of 4 ml enriched Middlebrook 7H9 medium (Bactec 12B; Becton Dickinson, 
Sparks, Md.) with 200 µl PANTA PLUS (Becton Dickinson), 1 ml egg yolk, 5 µg  mycobactin 
J (Allied Monitor Inc., Fayette, Mo.) and 0.7 ml water 1. The vials were incubated at 37 oC for 
up to 12 weeks and growth indices were measured weekly with an automatic ion chamber 
(BACTEC 460; Johnston Laboratories, Towson, Md). Samples yielding a positive growth 
index were then assayed by PCR with REA1. 
 
1.4.8 Histopathology 
 
Tissues (above) were processed routinely for histopathology, sectioned at 5 µm, stained with 
haematoxylin & eosin (H&E) and a Ziehl-Neelsen technique (ZN), and examined by light 
microscopy.   
 
Table 1:  Experimental design 
Group No. of 
lambs 
M ptb  per 
dose 
(intended) 
Freq of 
dosing 
Total  
dose 
(intended) 
Clinical sampling, 
week number 
Time of 
necropsy 
s: control 5 0 3x1 wk 0  0,2,4,6,7 wk 7 
s: low dose 6 102  .. 3x102 .. .. 
s: medium dose 6 104 .. 3x104 .. .. 
s: high dose 3 108 .. 3x108 .. .. 
e: control 5 0 10x1 wk 0 0,2,4,6,8,10,12,14 wk 14 
e: low dose 6 102  .. 103 .. .. 
e: medium dose 6 104 .. 105 .. .. 
e: high dose 3 108 .. 109 .. .. 
       
s = short regime (3 doses one week apart)    e = extended regime (10 doses one week apart)    
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1.5 Results 
 
1.5.1 Quantification of M. avium subsp. Paratuberculosis dose 
 
The direct counts conducted by microscopy and the MPN estimations conducted by culture 
for each neat suspension used in the preparation of inocula are given in Table 2. MPN 
estimations for viable M. avium subsp. paratuberculosis were up to 2 logs lower than the 
direct counts. The actual numbers of viable M. avium subsp. paratuberculosis organisms in 
each dose were about one log lower than the intended dose (Table 3). 
 
Table 2:  Direct microscopic counts of M. avium subsp. paratuberculosis compared to MPN 
estimates of viable organisms in suspensions used to prepare experimental inocula. 
Suspension   Log10 Direct 
count 
Log10  MPN 
estimation  
95% confidence limits for 
MPN estimation 
 
     lower upper 
Weeks 0,1,2 day prepared at week 0 10.3 8.52 8.04 8.97 
  at week 2 10.3 8.04 7.49 8.40 
Weeks 3,4,5 day prepared at week 3 10.3 9.11 8.54 9.48 
  at week 5 10.3 7.90 7.40 8.28 
Weeks 6,7,8,9 day prepared at week 6 10.2 8.23 7.65 8.69 
  at week 9 10.3 7.0*   
* No MPN estimate was possible due to media contamination. The figure given is an estimate based on previous 
storage experiments in PBS and the other suspensions in this experiment.  
 
Table 3:  Intended and actual doses of M. avium subsp. paratuberculosis 
Group M paratb per 
dose (intended) 
M paratb per 
dose (actual) 
Freq of 
dosing 
Total dose 
(intended) 
Total dose 
(actual) 
S: control 0 0 3x1 wk 0 0 
S: low dose 102  8.7x100 .. 3x102 2.6x101 
S: med dose 104 8.7x102 .. 3x104 2.6x103 
S: high dose 108 4.4x106 .. 3x108 1.3x107 
E: control 0 0 10x1 wk 0 0 
E: low dose 102  8.2x100 .. 103 8.2x101 
E: med dose 104 8.2x102 .. 105 8.2x103 
E: high dose 108 6.9x106 .. 109 6.9x107 
      
s = short regime (3 doses one week apart)    e = extended regime (10 doses one week apart)    
 
1.5.2 Serology for antibodies to M avium subsp. paratuberculosis 
 
One sheep (number 40) from the high dose group gave a positive EIA result at week 14, 
using the recommended interpretation criteria. No positive results were obtained for any 
other sheep or at any other time during this trial. (See Appendix 3 for full tabulation of 
results). 
 
1.5.3 Gamma interferon assay 
 
In the first run of the EIA, many samples, including unstimulated controls, gave very high 
optical densities but there was an apparently random pattern. This appeared to be related to 
plasma clots that formed in the tubes after thawing. The spurious high values were not seen 
when the assay was repeated after centrifugation of the thawed plasma samples. The 
corrected optical density values (PPD-stimulated minus nil-antigen) from the latter assay are 
given in Table 4. (Complete results are given in Appendix 2). The positive-negative cutt-off 
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was arbitrarily defined as the mean plus 3 standard deviations of the day 0 values (0.029 + 3 
x 0.053 = 0.188). Assuming a normal distribution of test results, 99% of truly negative 
samples would have an optical density lower than the cut-off. Using the cut-off of 0.188,  two 
sheep (number 8 from the control group and number 28 from the medium dose group) had 
positive values on day 0 (i.e. before dosing), and these values tended to remain elevated, 
although not always  exceeding the cut-off, in subsequent samplings. Sheep 34 (medium 
dose) had positive values at every sampling, except day 0 when the value approached the 
cut-off point. Three other sheep (number 31 from the medium dose groups, and numbers 36 
and 38 from the high dosed groups) had positive values on at least one occasion from seven 
weeks after the first dose. The gamma-interferon responses were compared between groups 
at each sampling time with a non-parametric test (Mood’s median test, Minitab statistical 
software). There were significant differences between group medians for weeks 8 and 14 
(high > control) (P<0.05). 
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1.5.4 Intradermal testing for delayed hypersensivity  
 
The skin thickness was measured immediately before and 72 hours after intradermal 
injection of 0.1 ml Johnin. An increase in thickness of > 0.5 mm was considered a positive 
reaction. One of three high dose, short regime lambs (number 36) was positive at 6 weeks 
Table 4. Gamma-interferon results, Avian PPD minus nil-antigen
W eek of sampling after first dose
Sheep 0 2 4 6 7 8 10 12 14
Undosed controls 
1 0.000 0.018 0.018 0.020 0.005
2 0.000 0.019 0.005 0.006 0.028
3 -0.015 0.000 0.000 -0.009 0.008
7 0.004 0.006 0.019 0.016 0.085
8 0.205 0.053 0.088 0.059 0.048
4 -0.001 0.012 -0.006 0.010 -0.002 0.004 0.000 -0.006
5 0.022 0.031 0.029 0.022 0.001 0.026 0.014 0.012
6 0.040 -0.051 0.065 0.048 -0.001 -0.042 0.003 0.009
9 0.006 -0.007 0.002 0.005 0.003 -0.129 0.005 0.030
10 0.154 -0.071 0.094 0.115 0.021 0.107 -0.003 -0.023
Means 0.042 0.001 0.031 0.029 0.035 0.004 -0.007 0.004 0.004
Low dose 
11 0.007 0.013 0.011 0.004 0.017
12 0.007 0.007 -0.066 0.003 0.017
13 0.010 0.008 0.005 0.021 0.007
14 0.010 -0.001 0.021 0.003 0.052
15 0.002 0.004 0.018 0.046 0.073
16 0.004 0.038 0.023 0.017 0.016
17 0.046 0.016 -0.010 0.006 0.023 0.099 0.038 0.050
18 0.003 0.010 -0.002 0.005 0.006 0.006 -0.003 0.013
19 0.020 0.010 -0.014 0.010 -0.013 0.024 0.004 0.055
20 0.009 -0.004 0.011 0.013 0.016 0.015 0.009 -0.030
21 0.007 0.019 0.006 0.007 0.033 0.028 0.003 0.142
22 0.004 0.021 0.001 -0.001 0.169 -0.014 -0.003 0.033
Means 0.011 0.012 0.000 0.011 0.030 0.039 0.026 0.008 0.044
M edium dose
23 0.015 0.035 0.065 0.023 0.037
24 -0.008 -0.005 0.001 0.017 0.024
25 0.047 0.008 0.011 -0.001 0.019
26 0.020 -0.004 0.008 0.000 0.001
27 0.018 -0.006 -0.003 0.001 0.040
28 0.203 0.072 0.589 0.028 0.120
29 0.008 0.000 0.004 -0.004 0.013 -0.002 -0.002 0.013
30 0.051 0.025 0.080 0.020 0.073 0.053 0.004 -0.007
31 0.009 0.008 0.012 0.010 0.041 0.003 0.204 0.002
32 0.001 0.023 0.029 0.008 0.007 0.049 0.011 0.012
33 0.001 0.009 0.031 0.002 0.026 0.116 0.012 -0.041
34 0.123 0.260 0.425 0.339 0.555 0.245 0.225 0.269
Means 0.041 0.035 0.104 0.037 0.040 0.119 0.077 0.076 0.041
High dose
35 -0.003 0.005 0.005 0.001 0.084
36 0.084 0.076 0.120 0.036 0.228
37 0.009 -0.002 0.001 -0.007 0.023
38 -0.005 0.014 0.011 -0.003 0.230 0.038 0.096 0.300
39 0.049 0.028 0.063 0.030 0.104 0.159 0.068 0.032
40 0.008 0.006 0.007 0.003 0.039 0.090 0.103 0.052
Means 0.024 0.021 0.035 0.010 0.112 0.124 0.096 0.089 0.128
* *
Positive samples positive using cut-off point 0.188 (Day 0 mean + 3 standard deviations)
* Medians for these groups exceed controls (P< 0.05, Moon's m edian test)
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after the first dose, and all three high dose, long regime lambs (numbers 38,39,40) were 
positive 13 weeks after the first dose. One low dose, long regime sheep (number 20) had an 
equivocal reaction (thickness increase 0.5 mm) at week 13 and all other sheep were 
negative. Using tissue culture (see below) as the gold standard test, the sensitivity of skin 
testing was 66% overall (100% for the lambs necropsied at week 14) and the  specificity was 
100%. (Detailed results for each lamb are given in Appendix 1). 
 
1.5.5 Faecal culture 
 
All cultures from faecal samples collected fortnightly were negative suggesting that there was 
no excretion of M. avium subsp. paratuberculosis during the trial. However, positive results 
were obtained from some of the faecal samples collected daily. Three sheep in the high dose 
groups were culture positive on 4 separate occasions between days 1 to 6 after dosing. The 
latter results are consistent with passive shedding of orally-dosed organisms. (See Appendix 
5 for complete results).  
 
1.5.6 Gross pathology 
 
No significant gross lesions were present in any sheep. 
 
1.5.7 Histopathology 
 
No lesions were present in any tissue in any sheep. ZN stained sections revealed a clump of 
three acid-fast organisms in a macrophage in a single lymph node from one high dose, short 
regime lamb (number 35). No other tissue from this or any other sheep had visible acid-fast 
organisms. 
 
1.5.8 Culture of tissues for M. avium subsp. paratuberculosis 
 
One or more tissues from each sheep in the high dose groups were culture positive however, 
none of the sheep in the control, low or medium dose groups had culture positive tissues 
(Table 5). The organism was recovered from at least one tissue of all 6 sheep which had 
received the high dose level, for both short and extended dosing regimes (7 and 14 weeks 
after first infection). M. avium subsp. paratuberculosis was recovered from the terminal ileum 
of 4 sheep, the ileocaecal valve of  3 sheep, the mesenteric lymph nodes of 4 sheep, the 
tonsil of 2 sheep and the jejunum of 1 sheep. The contamination rate for these 600 tissue 
cultures was zero, i.e. M. avium subsp. paratuberculosis was confirmed by PCR in each 
culture that developed a growth index.  (Complete results are given in Appendix 4). 
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1.6 Discussion 
 
Infection of weaned Merino lambs with an Australian isolate of an ovine strain of M. avium 
subsp. paratuberculosis was demonstrated, with total doses from about 107 to 108 viable 
organisms.  A total dose of 104 or fewer organisms did not produce detectable infection in 
this trial. Thus we have demonstrated that the lowest infectious dose for lambs under these 
experimental conditions is somewhere between  104 and 107  viable organisms. Apart from a 
single trial in which Brotherston et al 6 infected lambs with  103 organisms, most previous 
experimental infections in sheep have used doses in excess of 109, and often greater than 
1010 organisms7 8-12. It is important to realise that lambs in this trial were successfully infected 
with doses ranging from 0.1% to 1% of those used in most of the research trials conducted 
worldwide to date.  
 
With regard to the lowest infectious doses reported by Brotherston et al6 , we were unable to 
infect lambs with similar levels. However, there were significant differences in the methods of 
quantification of the organisms between the present trial and that of Brotherston et al6 . 
Brotherston et al 6 used colony counts on solid media to estimate the number of organisms. 
Our experience is that under ideal cultural conditions the number of viable M. avium subsp. 
paratuberculosis obtained by this technique may be at least 10-fold lower than that obtained 
using liquid Bactec media. Moreover, the organisms used by Brotherston et al6 had cultural 
characteristics of the bovine strain of M. avium subsp. paratuberculosis. This strain has a 
pronounced tendency to form clumps when attempts are made to form a suspension, and 
this results in significant underestimation of the actual count when plate counting methods 
are used. Thus their low dose was probably in excess 104 and possibly in excess of 105 
organisms. Nevertheless, it would appear from the results of the present trial where accurate 
enumeration techniques were employed that the infectious dose of ovine strain M. avium 
subsp. paratuberculosis may be somewhat higher than previously imagined. 
 
We have previously quantified numbers of M. avium subsp. paratuberculosis in faeces from 
known infected sheep, and measured levels up to 108 organisms per gram13. Because of the 
elaborate decontamination procedure required to isolate M. avium subsp. paratuberculosis 
from faecal material, this measured number of organisms may be about one hundred-fold 
less than the likely real value14. Thus levels of  1010 organisms per gram of faeces are 
Table 5: Culture results, high dose groups
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35 Short - - - - p p - - - p p p - - p
36 Short - - p - - - - - - - p - - - -
37 Short - - - p - - - - - - - - - - -
38 Extended - - - - - - - - - - - - - - p
39 Extended - - p p - p - - - p p - - - -
40 Extended - - p p p - p p - p p p p - -
p = positive
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possible in sheep with multibacillary paratuberculosis. In the field, ingestion of gram 
quantities of faeces is quite likely, especially over time, so that lambs in a paddock with 
infected sheep would certainly be exposed to such levels, which are 100 to 1000-fold above 
the levels we have demonstrated to be infectious in this trial. Moreover, we infected sheep 
using cultured organisms, and it is possible that cultured organisms may be less pathogenic 
than those excreted by infected sheep.  
 
In other words, for reasons outlined above we believe sheep in the field are likely to be 
exposed to levels of contamination as high or higher than those used in this trial, and the 
infectious dose for sheep exposed to natural faecal material may be lower than that 
measured in this trial. However, contamination levels on pasture after infected sheep have 
been removed will drop over time. “Hot spots” in spelled paddocks, such as around sheep 
camps, watering points, hand feeding areas etc could have high residual levels, even long 
after average levels of contamination on pasture dropped below an infectious level. The 
chance of exposure of lambs to infective levels of M. avium subsp. paratuberculosis in the 
field can only be assessed by extending the laboratory “tracer weaner” model to a controlled 
paddock trial. 
 
The use of the skin test to assess cell mediated immunity to M. avium subsp. 
paratuberculosis was surprisingly successful. We detected 100% of culture-confirmed 
infected sheep at the high dose, extended regime, and 66% of culture-confirmed infected 
sheep overall, with 100% specificity. In cattle, skin testing is rarely used because it has been 
found repeatedly to have both low sensitivity and low specificity15. However, while most 
reports suggest that the sensitivity of the skin test is quite low in adult sheep16, the specificity 
can be high, both in the experimental situation 17  and in the field16. Little attention has been 
paid to lambs, but early experimental work suggests that skin testing can be quite sensitive 
soon after infection, with responses declining over time18. It is important to note that the 
results in our trial were obtained for young lambs in an animal house situation and probably 
with minimal exposure to environmental mycobacteria which might stimulate cross-reactivity 
in the skin test. Thus we were able to use a relatively small increase in skin thickness 
(>0.5mm) as a positive criterion without loss of specificity. For adult sheep in overseas work, 
an increase in skin thickness of >4mm is used. The simplicity of the skin test would make it 
ideal for use in the field situation to monitor exposure of tracer lambs, hopefully allowing 
targeted necropsy and culture to confirm infection status. It should be investigated in a 
controlled field trial. 
 
There was also some evidence for the development of cell-mediated immunity to M. avium 
subsp. paratuberculosis in the gamma-interferon results of  these lambs, the high dose group 
having significantly higher medians than the control group at weeks 8 and 14. Considering 
individual sheep, two (numbers 36 and 38) of six high dose animals had elevated values on 
at least one occasion beyond week 7, and interestingly both of these also had positive 
results in the skin test. However, three other sheep (numbers 8, 28 and 34) had elevations of 
similar or greater magnitude that were quite unrelated to any exposure to M. avium subsp. 
paratuberculosis. This lack of specificity would limit the use of this test in the very early 
stages of the disease in lambs. Further research with assessment of sheep at later times 
after infection and with alternative positive-negative cut-off points might be worthwhile. 
 
As expected there was little evidence for serological response to M. avium subsp. 
paratuberculosis in this trial with only one animal showing a positive result at the final 
sampling. 
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The use of the skin test in this trial, one week before the final sample for other immunologic 
tests, was also designed to provide an anamnestic stimulus for those tests. We did not see 
any obvious evidence for this in the results. The single positive result in the final ELISA for 
serum antibodies in one high dose animal only is suggestive but no conclusions can be 
drawn. In the gamma-interferon test, 3 sheep had positive results one week after skin testing. 
Animals 36 (week 7) and 38 (week 14) were positive on the skin test indicating that a CMI 
response was already present and sheep 34 had consistently shown high levels from 
repeated samplings. No conclusions can be drawn from these results. Again, further 
research should be contemplated. 
 
Some discussion is warranted regarding the isolation of M. avium subsp. paratuberculosis 
from the faeces of experimental animals between 1 and 6 days after dosing. This probably 
represents passive excretion . The timing is as previously reported for passive excretion in 
cattle 19-22 , an event which was demonstrated to follow the same pattern as inert particulate 
matter19. Juste et al 23 cultured the organism from faeces of lambs up to 10 days after 
experimental infection with 150 mg wet wt of  M. avium subsp. paratuberculosis (probably 
about 1010 organisms). In the present trial passive excretion was demonstrated after doses 
as small as 4.4 x 106 organisms in lambs which had no gross or histological evidence of 
paratuberculosis, although the organism was later recovered at necropsy from the tissues. 
Thus an occasional animal in an infected flock will be positive on faecal culture, and itself 
have little evidence for infection at necropsy. Due to passive excretion the specificity of 
faecal culture for M. avium subsp. paratuberculosis for the disease status of an individual 
animal may be less than 100%; if, however it is taken as a measure of infection in the flock, 
100% specificity would be expected.  
 
It is important to appreciate that the present trial aimed to study only the initial infection of 
lambs with M. avium subsp. paratuberculosis. Whether individual infected lambs would go on 
to eliminate the organism, become chronic asymptomatic carriers or clinical cases cannot be 
assessed from such a short -duration trial. Nonetheless, we did detect infection with viable 
M. avium subsp. paratuberculosis in sheep tissues, including extra-intestinal tissues, five 
weeks after the last exposure to the organism, indicating a carrier state at that time. These 
lambs were certainly at risk of becoming subclinical or clinical cases of Johne's disease, and 
a potential source of infection to other sheep. However, the ultimate fate of these sheep is 
not important in the context of the tracer-weaner model.   
 
1.7 Success in achieving objectives 
 
Both objectives were achieved. The Australian sheep strain of M. avium subsp. 
paratuberculosis  was shown to be capable of infecting sheep and colonising the intestine of 
weaners after realistic doses. This colonisation could be detected within a few months of 
giving the first dose. An experimental system has been developed for M. avium subsp. 
paratuberculosis infection and this can be used for further work on pathogenesis and early 
diagnostic tests. 
 
1.8 Impact on Meat and Livestock Industry 
 
It is difficult to forecast an immediate or long term impact from this work until a controlled field 
trial has been undertaken. The concept of infecting weaners and then detecting the infection  
has worked very well in a pen trial but it is not possible to extrapolate these findings to the 
real world. In nature doses of the organism may be acquired over a prolonged period, 
animals would be exposed to a wide variety of environmental bacteria and there may be 
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considerable differences in degree and timing of exposure between farms and geographic 
regions. Application of the tracer weaner concept in the national program is still some way 
off. However, there are some direct and useful outcomes from the work completed so far. 
The collective impacts are: 
 
A field trial of the tracer weaner concept is justifiable based on trial results to date. 
 
The infectious dose of M. avium subsp. paratuberculosis appears to be higher than 
previously thought. This finding should be greeted with optimism because it reinforces the 
concept that spelling land after removing infected sheep is a viable means of ridding a farm 
of ovine Johne’s disease. It may mean that spelling periods can be reduced. This finding 
needs to be considered together with the results from separate trials on the duration of 
survival of the organism in soils. 
 
A useful means of infecting weaners under controlled experimental conditions has been 
developed. It employs relatively low doses of the organism that may reflect natural levels of 
exposure and it uses small group sizes. Other experimental models in current use employ 
unrealistically high doses and cause an unnatural kind of infection in which too large a 
proportion of animals develop too severe an infection too quickly. The results from such trials 
are unlikely to be representative of field situations. The new infection model may be 
applicable in other studies of diagnostic tests, vaccines and the pathogenesis of ovine 
Johne’s disease and is likely to provide a better indication of what can be expected in nature. 
 
1.9 Conclusion and recommendations 
 
Infection with M. avium subsp. paratuberculosis was demonstrated at 7 or 14 weeks after 
first exposure in each of 6 lambs given total oral doses of 1.3 to 6.9 x 107 viable organisms. 
There were no associated gross or microscopic lesions due to the short duration of this trial. 
Only one lamb gave a positive result in ELISA for antibodies to M. avium subsp. 
paratuberculosis. There was some correlation between gamma interferon test outcome and 
infection status, but this test lacked specificity. Intradermal testing with Johnin PPD enabled 
ante-mortem detection of all three culture-confirmed infected lambs at 13 weeks, and one of 
three culture-confirmed infected lambs at 6 weeks after first exposure to M. avium subsp. 
paratuberculosis with 100% specificity. The results from this trial suggest that the tracer 
weaner concept should be evaluated in the field. 
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3. APPENDICES 
 
Appendix 1:  Skin test results 
Sheep  Schedule Dose Skin thickness, 0 hr Skin thickness, 72 hr Increase Swelling 
      
Meas 
1 
Meas 
2 Average 
Meas 
1 
Meas 
2 Average     
           
1 Short Control 0.8 1.0 0.90 0.7 0.8 0.75 -0.15 - 
2 Short Control 1.2 1.0 1.10 1.1 1.0 1.05 -0.05 - 
3 Short Control 1.0 0.8 0.90 0.7 1.0 0.85 -0.05 - 
4 Extended Control 0.6 0.7 0.65 1.1 0.9 1.00 0.35 - 
5 Extended Control 0.7 0.8 0.75 0.9 0.7 0.80 0.05 - 
6 Extended Control 0.8 0.6 0.70 0.6 0.7 0.65 -0.05 - 
7 Short Control 1.0 1.0 1.00 1.0 0.8 0.90 -0.10 - 
8 Short Control 1.1 1.0 1.05 1.0 1.0 1.00 -0.05 - 
9 Extended Control 0.7 0.6 0.65 0.9 1.0 0.95 0.30 - 
10 Extended Control 0.8 0.9 0.85 0.7 0.6 0.65 -0.20 - 
11 Short Low 1.0 0.9 0.95 0.9 0.6 0.75 -0.20 - 
12 Short Low 0.8 0.8 0.80 1.0 0.9 0.95 0.15 - 
13 Short Low 0.8 1.0 0.90 1.0 1.1 1.05 0.15 - 
14 Short Low 1.0 1.1 1.05 1.0 0.8 0.90 -0.15 - 
15 Short Low 0.9 0.9 0.90 1.0 1.0 1.00 0.10 - 
16 Short Low 0.8 0.8 0.80 0.9 1.0 0.95 0.15 - 
17 Extended Low 0.6 0.6 0.60 0.8 0.8 0.80 0.20 - 
18 Extended Low 0.8 0.7 0.75 0.7 0.9 0.80 0.05 - 
19 Extended Low 0.7 0.7 0.70 1.0 0.8 0.90 0.20 - 
20 Extended Low 0.6 0.6 0.60 1.0 1.2 1.10 0.50 10* 
21 Extended Low 0.9 0.9 0.90 1.0 0.6 0.80 -0.10 - 
22 Extended Low 0.8 0.6 0.70 0.8 0.8 0.80 0.10 - 
23 Short Medium 0.8 0.9 0.85 0.8 0.9 0.85 0.00 - 
24 Short Medium 1.1 0.9 1.00 0.9 1.0 0.95 -0.05 - 
25 Short Medium 1.0 0.9 0.95 1.1 0.9 1.00 0.05 - 
26 Short Medium 0.7 0.8 0.75 1.0 0.9 0.95 0.20 - 
27 Short Medium 1.0 1.1 1.05 1.0 1.1 1.05 0.00 - 
28 Short Medium 0.9 0.7 0.80 1.0 0.9 0.95 0.15 - 
29 Extended Medium 1.0 1.0 1.00 0.7 0.8 0.75 -0.25 - 
30 Extended Medium 0.8 0.6 0.70 1.1 0.9 1.00 0.30 - 
31 Extended Medium 0.5 0.6 0.55 0.9 0.9 0.90 0.35 - 
32 Extended Medium 0.9 0.9 0.90 0.9 0.9 0.90 0.00 - 
33 Extended Medium 0.8 0.8 0.80 0.6 0.7 0.65 -0.15 - 
34 Extended Medium 0.5 0.5 0.50 0.8 0.9 0.85 0.35 - 
35 Short High 1.1 1.0 1.05 0.9 0.9 0.90 -0.15 - 
36 Short High 1.1 1.0 1.05 1.9 1.9 1.90 0.85 15** 
37 Short High 1.0 1.1 1.05 0.9 0.8 0.85 -0.20 - 
38 Extended High 0.8 0.9 0.85 4.2 3.2 3.70 2.85 15** 
39 Extended High 0.7 0.5 0.60 2.6 2.7 2.65 2.05 15** 
40 Extended High 1.0 1.0 1.00 3.5 3.0 3.25 2.25 25** 
* Equivocal slight swelling without obvious borders. 
** Plaque-like irregular area of induration without redness, distinct borders. 
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Appendix 2:  BOVIGAM, Bovine gamma interferon test results 
EIA using uncentrifuged thawed plasma samples 
 week 14 
Sheep Optical densities at 450 nm 
  control avian bovine av-con bo-con 
1      
2      
3      
4 0.293 0.303 0.310 0.010 0.017 
5 0.437 0.539 0.432 0.102 -0.005 
6 0.287 0.312 0.260 0.025 -0.027 
7      
8      
9 0.311 0.365 0.347 0.054 0.036 
10 0.278 0.289 0.228 0.011 -0.050 
control group means  0.040 -0.006 
      
11      
12      
13      
14      
15      
16      
17 0.137 0.185 0.150 0.048 0.013 
18 0.400 0.465 0.714 0.065 0.314 
19 0.132 0.191 0.252 0.059 0.120 
20 0.290 0.311 0.338 0.021 0.048 
21 0.198 0.401 0.294 0.203 0.096 
22 0.253 0.285 0.251 0.032 -0.002 
low group means  0.071 0.098 
      
23      
24      
25      
26      
27      
28      
29 0.275 0.265 0.265 -0.010 -0.010 
30 0.119 0.189 0.134 0.070 0.015 
31 0.402 0.409 0.405 0.007 0.003 
32 0.472 0.447 0.508 -0.025 0.036 
33 0.349 0.409 0.432 0.060 0.083 
34 0.352 0.973 0.730 0.621 0.378 
medium group means  0.121 0.084 
      
35      
36      
37      
38 0.107 0.569 0.235 0.462 0.128 
39 0.124 0.172 0.134 0.048 0.010 
40 0.098 0.216 0.164 0.118 0.066 
high group means  0.209 0.068 
(OD's for at least one antigen from first EIA were in excess of 0.5) 
(These samples selected for retest as most likely to be true positives) 
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Appendix 2:  BOVIGAM, Bovine gamma interferon test results 
Repeat EIA using centrifuged thawed plasma samples 
 week 0 week2 
Sheep Optical densities at 450 nm  Optical densities at 450 nm 
  control  avian bovine av-con bo-con   control avian bovine av-con bo-con 
1 0.036 0.036 0.043 0.000 0.007  0.030 0.048 0.045 0.018 0.015 
2 0.041 0.041 0.038 0.000 -0.003  0.039 0.058 0.042 0.019 0.003 
3 0.044 0.029 0.026 -0.015 -0.018  0.038 0.038 0.045 0.000 0.007 
4 0.037 0.036 0.037 -0.001 0.000  0.036 0.048 0.038 0.012 0.002 
5 0.047 0.069 0.062 0.022 0.015  0.032 0.063 0.062 0.031 0.030 
6 0.037 0.077 0.044 0.040 0.007  0.105 0.054 0.046 -0.051 -0.059 
7 0.035 0.039 0.029 0.004 -0.006  0.036 0.042 0.045 0.006 0.009 
8 0.075 0.280 0.122 0.205 0.047  0.040 0.093 0.037 0.053 -0.003 
9 0.045 0.051 0.036 0.006 -0.009  0.036 0.029 0.025 -0.007 -0.011 
10 0.043 0.197 0.050 0.154 0.007  0.108 0.037 0.046 -0.071 -0.062 
control group means  0.042 0.005     0.001 -0.007 
            
11 0.026 0.033 0.255 0.007 0.229  0.038 0.051 0.032 0.013 -0.006 
12 0.032 0.039 0.036 0.007 0.004  0.033 0.040 0.036 0.007 0.003 
13 0.034 0.044 0.041 0.010 0.007  0.036 0.044 0.043 0.008 0.007 
14 0.034 0.044 0.036 0.010 0.002  0.036 0.035 0.038 -0.001 0.002 
15 0.029 0.031 0.035 0.002 0.006  0.046 0.050 0.045 0.004 -0.001 
16 0.042 0.046 0.036 0.004 -0.006  0.033 0.071 0.046 0.038 0.013 
17 0.041 0.087 0.054 0.046 0.013  0.034 0.050 0.074 0.016 0.040 
18 0.035 0.038 0.033 0.003 -0.002  0.034 0.044 0.090 0.010 0.056 
19 0.030 0.050 0.041 0.020 0.011  0.034 0.044 0.096 0.010 0.062 
20 0.036 0.045 0.035 0.009 -0.001  0.047 0.043 0.065 -0.004 0.018 
21 0.047 0.054 0.049 0.007 0.002  0.039 0.058 0.038 0.019 -0.001 
22 0.033 0.037 0.092 0.004 0.059  0.037 0.058 0.036 0.021 -0.001 
low group means  0.011 0.027     0.012 0.016 
            
23 0.025 0.040 0.029 0.015 0.004  0.030 0.065 0.035 0.035 0.005 
24 0.047 0.039 0.042 -0.008 -0.005  0.039 0.034 0.042 -0.005 0.003 
25 0.042 0.089 0.052 0.047 0.010  0.052 0.060 0.047 0.008 -0.005 
26 0.038 0.058 0.073 0.020 0.035  0.040 0.036 0.036 -0.004 -0.004 
27 0.028 0.046 0.071 0.018 0.043  0.042 0.036 0.042 -0.006 0.000 
28 0.038 0.241 0.129 0.203 0.091  0.039 0.111 0.038 0.072 -0.001 
29 0.034 0.042 0.055 0.008 0.021  0.044 0.044 0.060 0.000 0.016 
30 0.049 0.100 0.057 0.051 0.008  0.032 0.057 0.053 0.025 0.021 
31 0.034 0.043 0.037 0.009 0.003  0.033 0.041 0.033 0.008 0.000 
32 0.038 0.039 0.038 0.001 0.000  0.034 0.057 0.037 0.023 0.003 
33 0.039 0.040 0.025 0.001 -0.014  0.036 0.045 0.049 0.009 0.013 
34 0.060 0.183 0.062 0.123 0.002  0.036 0.296 0.044 0.260 0.008 
medium group means  0.041 0.017     0.035 0.005 
            
35 0.057 0.054 0.058 -0.003 0.001  0.028 0.033 0.028 0.005 0.000 
36 0.051 0.135 0.039 0.084 -0.012  0.036 0.112 0.035 0.076 -0.001 
37 0.039 0.048 0.026 0.009 -0.013  0.049 0.047 0.037 -0.002 -0.012 
38 0.042 0.037 0.056 -0.005 0.014  0.037 0.051 0.064 0.014 0.027 
39 0.042 0.091 0.055 0.049 0.013  0.026 0.054 0.040 0.028 0.014 
40 0.058 0.066 0.032 0.008 -0.026  0.035 0.041 0.044 0.006 0.009 
high group means  0.024 -0.004     0.021 0.006 
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Appendix 2:  BOVIGAM, Bovine gamma interferon test results 
Repeat EIA using centrifuged thawed plasma samples 
 week 4  week 6 
Sheep Optical densities at 450 nm  Optical densities at 450 nm 
  control  avian bovine av-con bo-con   control avian bovine av-con bo-con 
1 0.045 0.063 0.049 0.018 0.004  0.053 0.073 0.041 0.020 -0.012 
2 0.037 0.042 0.041 0.005 0.004  0.039 0.045 0.034 0.006 -0.005 
3 0.028 0.028 0.032 0.000 0.004  0.056 0.047 0.304 -0.009 0.248 
4 0.044 0.038 0.067 -0.006 0.023  0.041 0.051 0.064 0.010 0.023 
5 0.043 0.072 0.053 0.029 0.010  0.048 0.070 0.050 0.022 0.002 
6 0.030 0.095 0.054 0.065 0.024  0.036 0.084 0.034 0.048 -0.002 
7 0.033 0.052 0.056 0.019 0.023  0.033 0.049 0.039 0.016 0.006 
8 0.085 0.173 0.077 0.088 -0.008  0.165 0.224 0.143 0.059 -0.022 
9 0.038 0.040 0.040 0.002 0.002  0.046 0.051 0.050 0.005 0.004 
10 0.045 0.139 0.067 0.094 0.022  0.074 0.189 0.117 0.115 0.043 
control group means  0.031 0.011     0.029 0.029 
            
11 0.036 0.047 0.101 0.011 0.065  0.043 0.047 0.031 0.004 -0.012 
12 0.108 0.042 0.032 -0.066 -0.076  0.034 0.037 0.071 0.003 0.037 
13 0.029 0.034 0.030 0.005 0.001  0.037 0.058 0.056 0.021 0.019 
14 0.040 0.061 0.054 0.021 0.014  0.037 0.040 0.042 0.003 0.005 
15 0.039 0.057 0.044 0.018 0.005  0.029 0.075 0.055 0.046 0.026 
16 0.036 0.059 0.046 0.023 0.010  0.038 0.055 0.046 0.017 0.008 
17 0.065 0.055 0.052 -0.010 -0.013  0.061 0.067 0.070 0.006 0.009 
18 0.037 0.035 0.071 -0.002 0.034  0.033 0.038 0.043 0.005 0.010 
19 0.063 0.049 0.049 -0.014 -0.014  0.035 0.045 0.045 0.010 0.010 
20 0.037 0.048 0.089 0.011 0.052  0.031 0.044 0.059 0.013 0.028 
21 0.030 0.036 0.028 0.006 -0.002  0.052 0.059 0.068 0.007 0.016 
22 0.035 0.036 0.038 0.001 0.003  0.034 0.033 0.033 -0.001 -0.001 
low group means  0.000 0.007     0.011 0.013 
            
23 0.040 0.105 0.043 0.065 0.003  0.034 0.057 0.050 0.023 0.016 
24 0.037 0.038 0.040 0.001 0.003  0.035 0.052 0.039 0.017 0.004 
25 0.032 0.043 0.041 0.011 0.009  0.046 0.045 0.044 -0.001 -0.002 
26 0.034 0.042 0.037 0.008 0.003  0.039 0.039 0.053 0.000 0.014 
27 0.082 0.079 0.058 -0.003 -0.024  0.037 0.038 0.039 0.001 0.002 
28 0.046 0.635 0.241 0.589 0.195  0.037 0.065 0.083 0.028 0.046 
29 0.030 0.034 0.033 0.004 0.003  0.037 0.033 0.046 -0.004 0.009 
30 0.050 0.130 0.056 0.080 0.006  0.035 0.055 0.054 0.020 0.019 
31 0.046 0.058 0.049 0.012 0.003  0.032 0.042 0.032 0.010 0.000 
32 0.032 0.061 0.044 0.029 0.012  0.029 0.037 0.030 0.008 0.001 
33 0.034 0.065 0.040 0.031 0.006  0.032 0.034 0.029 0.002 -0.003 
34 0.044 0.469 0.043 0.425 -0.001  0.036 0.375 0.057 0.339 0.021 
medium group means  0.104 0.018     0.037 0.011 
            
35 0.052 0.057 0.059 0.005 0.007  0.035 0.036 0.034 0.001 -0.001 
36 0.033 0.153 0.062 0.120 0.029  0.032 0.068 0.042 0.036 0.010 
37 0.033 0.034 0.031 0.001 -0.002  0.037 0.030 0.032 -0.007 -0.005 
38 0.034 0.045 0.085 0.011 0.051  0.043 0.040 0.043 -0.003 0.000 
39 0.036 0.099 0.048 0.063 0.012  0.031 0.061 0.049 0.030 0.018 
40 0.039 0.046 0.048 0.007 0.009  0.033 0.036 0.036 0.003 0.003 
high group means  0.035 0.018     0.010 0.004 
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Appendix 2:  BOVIGAM, Bovine gamma interferon test results 
Repeat EIA using centrifuged thawed plasma samples 
 week 7  week 8 
Sheep Optical densities at 450 nm  Optical densities at 450 nm 
  control  avian bovine av-con bo-con   control avian bovine av-con bo-con 
1 0.031 0.036 0.034 0.005 0.003       
2 0.043 0.071 0.046 0.028 0.003       
3 0.034 0.042 0.038 0.008 0.004       
4       0.042 0.040 0.040 -0.002 -0.002 
5       0.037 0.038 0.049 0.001 0.012 
6       0.033 0.032 0.035 -0.001 0.002 
7 0.041 0.126 0.083 0.085 0.042       
8 0.077 0.125 0.093 0.048 0.016       
9       0.036 0.039 0.039 0.003 0.003 
10       0.080 0.101 0.082 0.021 0.002 
control group means  0.035 0.014     0.004 0.003 
            
11 0.046 0.063 0.039 0.017 -0.007       
12 0.042 0.059 0.045 0.017 0.003       
13 0.039 0.046 0.127 0.007 0.088       
14 0.034 0.086 0.082 0.052 0.048       
15 0.041 0.114 0.061 0.073 0.020       
16 0.046 0.062 0.081 0.016 0.035       
17       0.043 0.066 0.049 0.023 0.006 
18       0.039 0.045 0.038 0.006 -0.001 
19       0.051 0.038 0.049 -0.013 -0.002 
20       0.041 0.057 0.052 0.016 0.011 
21       0.040 0.073 0.053 0.033 0.013 
22       0.032 0.201 0.045 0.169 0.013 
low group means  0.030 0.031     0.039 0.007 
            
23 0.070 0.107 0.092 0.037 0.022       
24 0.027 0.051 0.031 0.024 0.004       
25 0.044 0.063 0.049 0.019 0.005       
26 0.044 0.045 0.046 0.001 0.002       
27 0.061 0.101 0.068 0.040 0.007       
28 0.029 0.149 0.095 0.120 0.066       
29       0.035 0.048 0.048 0.013 0.013 
30       0.055 0.128 0.106 0.073 0.051 
31       0.042 0.083 0.043 0.041 0.001 
32       0.044 0.051 0.033 0.007 -0.011 
33       0.041 0.067 0.057 0.026 0.016 
34       0.052 0.607 0.104 0.555 0.052 
medium group means  0.040 0.018     0.119 0.020 
            
35 0.032 0.116 0.052 0.084 0.020       
36 0.056 0.284 0.104 0.228 0.048       
37 0.035 0.058 0.062 0.023 0.027       
38       0.037 0.267 0.048 0.230 0.011 
39       0.031 0.135 0.104 0.104 0.073 
40       0.043 0.082 0.065 0.039 0.022 
high group means  0.112 0.032     0.124 0.035 
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Appendix 2:  BOVIGAM, Bovine gamma interferon test results 
Repeat EIA using centrifuged thawed plasma samples 
 week 10  week 12 
Sheep Optical densities at 450 nm  Optical densities at 450 nm 
  control  avian bovine av-con bo-con   control avian bovine av-con bo-con 
1            
2            
3            
4 0.049 0.053 0.053 0.004 0.004  0.043 0.043 0.047 0.000 0.004 
5 0.039 0.065 0.051 0.026 0.012  0.057 0.071 0.066 0.014 0.009 
6 0.078 0.036 0.032 -0.042 -0.046  0.030 0.033 0.029 0.003 -0.001 
7            
8            
9 0.198 0.069 0.044 -0.129 -0.154  0.037 0.042 0.040 0.005 0.003 
10 0.077 0.184 0.105 0.107 0.028  0.036 0.033 0.036 -0.003 0.000 
control group means  -0.007 -0.031     0.004 0.003 
            
11            
12            
13            
14            
15            
16            
17 0.045 0.144 0.084 0.099 0.039  0.055 0.093 0.068 0.038 0.013 
18 0.031 0.037 0.056 0.006 0.025  0.038 0.035 0.035 -0.003 -0.003 
19 0.037 0.061 0.045 0.024 0.008  0.047 0.051 0.050 0.004 0.003 
20 0.042 0.057 0.076 0.015 0.034  0.040 0.049 0.061 0.009 0.021 
21 0.034 0.062 0.093 0.028 0.059  0.036 0.039 0.058 0.003 0.022 
22 0.055 0.041 0.036 -0.014 -0.019  0.032 0.029 0.037 -0.003 0.005 
low group means  0.026 0.024     0.008 0.010 
            
23            
24            
25            
26            
27            
28            
29 0.051 0.049 0.035 -0.002 -0.016  0.038 0.036 0.034 -0.002 -0.004 
30 0.037 0.090 0.066 0.053 0.029  0.035 0.039 0.039 0.004 0.004 
31 0.038 0.041 0.043 0.003 0.005  0.040 0.244 0.056 0.204 0.016 
32 0.038 0.087 0.047 0.049 0.009  0.034 0.045 0.036 0.011 0.002 
33 0.047 0.163 0.117 0.116 0.070  0.046 0.058 0.063 0.012 0.017 
34 0.043 0.288 0.131 0.245 0.088  0.060 0.285 0.137 0.225 0.077 
medium group means  0.077 0.031     0.076 0.019 
            
35            
36            
37            
38 0.044 0.082 0.061 0.038 0.017  0.036 0.132 0.113 0.096 0.077 
39 0.071 0.230 0.070 0.159 -0.001  0.032 0.100 0.089 0.068 0.057 
40 0.038 0.128 0.063 0.090 0.025  0.038 0.141 0.132 0.103 0.094 
high group means  0.096 0.014     0.089 0.076 
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Appendix 2:  BOVIGAM, Bovine gamma interferon test results 
Repeat EIA using centrifuged thawed plasma samples 
 week 14 
Sheep Optical densities at 450 nm 
  control  avian bovine av-con bo-con 
1      
2      
3      
4 0.052 0.046 0.054 -0.006 0.002 
5 0.137 0.149 0.136 0.012 -0.001 
6 0.046 0.055 0.046 0.009 0.000 
7      
8      
9 0.049 0.079 0.070 0.030 0.021 
10 0.187 0.164 0.146 -0.023 -0.041 
control group means  0.004 -0.004 
      
11      
12      
13      
14      
15      
16      
17 0.060 0.110 0.085 0.050 0.025 
18 0.046 0.059 0.054 0.013 0.008 
19 0.058 0.113 0.089 0.055 0.031 
20 0.074 0.044 0.045 -0.030 -0.029 
21 0.089 0.231 0.166 0.142 0.077 
22 0.044 0.077 0.043 0.033 -0.001 
low group means  0.044 0.019 
      
23      
24      
25      
26      
27      
28      
29 0.034 0.047 0.092 0.013 0.058 
30 0.076 0.069 0.063 -0.007 -0.013 
31 0.047 0.049 0.068 0.002 0.021 
32 0.040 0.052 0.055 0.012 0.015 
33 0.103 0.062 0.076 -0.041 -0.027 
34 0.051 0.320 0.221 0.269 0.170 
medium group means  0.041 0.037 
      
35      
36      
37      
38 0.037 0.337 0.158 0.300 0.121 
39 0.044 0.076 0.066 0.032 0.022 
40 0.034 0.086 0.082 0.052 0.048 
high group means  0.128 0.064 
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Appendix 3:  PARACHEK Johne's absorbed EIA test results 
 Week 0  Week 2  Week 4 
Sheep No. OD1 OD-B2   OD OD-B   OD OD-B 
1 0.058 0.018  0.084 0.042  0.092 0.053 
2 0.064 0.023  0.089 0.047  0.087 0.048 
3 0.113 0.072  0.094 0.052  0.108 0.069 
4 0.147 0.107  0.107 0.065  0.123 0.084 
5 0.063 0.022  0.088 0.046  0.115 0.076 
6 0.062 0.022  0.093 0.051  0.108 0.069 
7 0.055 0.015  0.083 0.041  0.097 0.058 
8 0.090 0.050  0.079 0.037  0.113 0.074 
9 0.124 0.084  0.105 0.063  0.147 0.108 
10 0.064 0.024  0.083 0.041  0.139 0.100 
11 0.069 0.028  0.080 0.038  0.153 0.114 
12 0.066 0.026  0.093 0.051  0.126 0.087 
13 0.066 0.026  0.093 0.051  0.278 0.239 
14 0.052 0.012  0.067 0.025  0.114 0.075 
15 0.076 0.035  0.101 0.059  0.126 0.087 
16 0.087 0.047  0.100 0.058  0.150 0.111 
17 0.096 0.056  0.087 0.045  0.110 0.071 
18 0.145 0.105  0.111 0.069  0.129 0.090 
19 0.059 0.019  0.085 0.043  0.099 0.060 
20 0.079 0.038  0.157 0.115  0.146 0.107 
21 0.078 0.037  0.087 0.045  0.119 0.080 
22 0.064 0.024  0.104 0.062  0.093 0.054 
23 0.062 0.021  0.103 0.061  0.101 0.062 
24 0.106 0.066  0.101 0.059  0.107 0.068 
25 0.061 0.021  0.101 0.059  0.094 0.055 
26 0.071 0.031  0.100 0.058  0.114 0.075 
27 0.071 0.031  0.117 0.075  0.121 0.082 
28 0.062 0.021  0.090 0.048  0.085 0.046 
29 0.061 0.020  0.090 0.048  0.084 0.045 
30 0.064 0.023  0.148 0.106  0.147 0.108 
31 0.064 0.023  0.110 0.068  0.102 0.063 
32 0.065 0.025  0.095 0.053  0.101 0.062 
33 0.083 0.042  0.094 0.052  0.087 0.048 
34 0.062 0.022  0.078 0.036  0.064 0.025 
35 0.062 0.022  0.084 0.042  0.039 0.000 
36 0.058 0.017  0.097 0.055  0.040 0.001 
37 0.070 0.029  0.082 0.040  0.117 0.078 
38 0.064 0.024  0.078 0.036  0.082 0.043 
39 0.072 0.031  0.084 0.042  0.078 0.039 
40 0.096 0.056  0.111 0.069  0.040 0.001 
         
+ve control OD 1.133 1.092  1.064 1.022  1.029 0.990 
-ve control OD 0.105 0.065  0.081 0.039  0.076 0.037 
blank OD 0.041   0.042   0.039  
cut-off3 0.205 0.165  0.181 0.139  0.176 0.137 
1 All optical density (OD) values reported are means of duplicate readings. 
2  "Corrected optical densities" (sample OD minus Blank OD). 
3 This value is the negative control OD plus 0.1, as per manufacturer's recommendation. 
  Test repeated:OD 0.063, cut-off 0.188. 
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Appendix 3:  PARACHEK, Johne's absorbed EIA test results 
  Week 6  Week 7  Week 8 
Sheep No.   OD1 OD-B2   OD OD-B   OD OD-B 
1  0.136 0.091  0.096 0.056    
2  0.099 0.054  0.085 0.045    
3  0.114 0.069  0.097 0.057    
4  0.121 0.076     0.105 0.065 
5  0.099 0.054     0.087 0.047 
6  0.104 0.059     0.084 0.044 
7  0.096 0.051  0.094 0.054    
8  0.094 0.049  0.083 0.043    
9  0.125 0.080     0.093 0.053 
10  0.095 0.050     0.097 0.057 
11  0.104 0.059  0.087 0.047    
12  0.099 0.054  0.080 0.040    
13  0.110 0.065  0.115 0.075    
14  0.082 0.037  0.078 0.038    
15  0.102 0.057  0.122 0.082    
16  0.104 0.059  0.078 0.038    
17  0.112 0.067     0.067 0.027 
18  0.114 0.069     0.090 0.050 
19  0.086 0.041     0.106 0.066 
20  0.124 0.079     0.091 0.051 
21  0.117 0.072     0.133 0.093 
22  0.081 0.036     0.101 0.061 
23  0.086 0.041  0.108 0.068    
24  0.095 0.050  0.123 0.083    
25  0.099 0.054  0.086 0.046    
26  0.104 0.059  0.167 0.127    
27  0.096 0.051  0.107 0.067    
28  0.090 0.045  0.079 0.039    
29  0.115 0.070     0.118 0.078 
30  0.108 0.063     0.096 0.056 
31  0.109 0.064     0.093 0.053 
32  0.088 0.043     0.073 0.033 
33  0.138 0.093     0.153 0.113 
34  0.106 0.061     0.078 0.038 
35  0.117 0.072  0.087 0.047    
36  0.104 0.059  0.078 0.038    
37  0.106 0.061  0.113 0.073    
38  0.100 0.055     0.082 0.042 
39  0.113 0.068     0.081 0.041 
40  0.107 0.062     0.082 0.042 
          
+ve control  0.984 0.939  1.172 1.132  1.172 1.132 
-ve control  0.086 0.041  0.074 0.034  0.074 0.034 
blank  0.045   0.040   0.040  
cut-off3  0.186 0.141  0.174 0.134  0.174 0.134 
1 All optical density (OD) values reported are means of duplicate readings. 
2  "Corrected optical densities" (sample OD minus Blank OD). 
3 This value is the negative control OD plus 0.1, as per manufacture's recommendation. 
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Appendix 3:  PARACHEK, Johne's absorbed EIA test results 
 Week 10  Week 12  Week 14 
Sheep No. OD1 OD-B2   OD OD-B   OD OD-B 
1         
2         
3         
4 0.107 0.067  0.086 0.046  0.119 0.080 
5 0.100 0.060  0.083 0.043  0.111 0.071 
6 0.105 0.065  0.102 0.062  0.122 0.083 
7         
8         
9 0.138 0.098  0.104 0.064  0.138 0.099 
10 0.098 0.058  0.087 0.047  0.117 0.077 
11         
12         
13         
14         
15         
16         
17 0.080 0.040  0.084 0.044  0.077 0.037 
18 0.097 0.057  0.080 0.040  0.096 0.057 
19 0.085 0.045  0.087 0.047  0.137 0.097 
20 0.102 0.062  0.172 0.132  0.094 0.055 
21 0.094 0.054  0.117 0.077  0.124 0.085 
22 0.086 0.046  0.101 0.061  0.120 0.081 
23         
24         
25         
26         
27         
28         
29 0.075 0.035  0.095 0.055  0.112 0.073 
30 0.089 0.049  0.138 0.098  0.105 0.065 
31 0.080 0.040  0.105 0.065  0.091 0.052 
32 0.069 0.029  0.081 0.041  0.126 0.087 
33 0.143 0.103  0.174 0.134  0.127 0.088 
34 0.083 0.043  0.040 0.000  0.120 0.081 
35         
36         
37         
38 0.081 0.041  0.043 0.003  0.115 0.075 
39 0.063 0.023  0.049 0.009  0.109 0.069 
40 0.106 0.066  0.043 0.003  0.252 0.212 
         
+ve control 1.140 1.100  1.140 1.100  1.032 0.992 
-ve control 0.082 0.042  0.082 0.042  0.075 0.036 
blank 0.040   0.040   0.040  
cut-off3 0.182 0.142  0.182 0.142  0.175 0.136 
1 All optical density (OD) values reported are means of duplicate readings. 
2  "Corrected optical densities" (sample OD minus Blank OD). 
3 This value is the negative control OD plus 0.1, as per manufacture's recommendation. 
  Test repeated:OD 0.194, cut-off 0.188. 
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Appendix 4:  Culture results, tissues collected at necropsy 
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1 Short Control - - - - - - - - - - - - - - - 
2 Short Control - - - - - - - - - - - - - - - 
3 Short Control - - - - - - - - - - - - - - - 
7 Short Control - - - - - - - - - - - - - - - 
8 Short Control - - - - - - - - - - - - - - - 
4 Extended Control - - - - - - - - - - - - - - - 
5 Extended Control - - - - - - - - - - - - - - - 
6 Extended Control - - - - - - - - - - - - - - - 
9 Extended Control - - - - - - - - - - - - - - - 
10 Extended Control - - - - - - - - - - - - - - - 
11 Short Low - - - - - - - - - - - - - - - 
12 Short Low - - - - - - - - - - - - - - - 
13 Short Low - - - - - - - - - - - - - - - 
14 Short Low - - - - - - - - - - - - - - - 
15 Short Low - - - - - - - - - - - - - - - 
16 Short Low - - - - - - - - - - - - - - - 
17 extended Low - - - - - - - - - - - - - - - 
18 extended Low - - - - - - - - - - - - - - - 
19 extended Low - - - - - - - - - - - - - - - 
20 extended Low - - - - - - - - - - - - - - - 
21 extended Low - - - - - - - - - - - - - - - 
22 extended Low - - - - - - - - - - - - - - - 
23 Short Medium - - - - - - - - - - - - - - - 
24 Short Medium - - - - - - - - - - - - - - - 
25 Short Medium - - - - - - - - - - - - - - - 
26 Short Medium - - - - - - - - - - - - - - - 
27 Short Medium - - - - - - - - - - - - - - - 
28 Short Medium - - - - - - - - - - - - - - - 
29 extended Medium - - - - - - - - - - - - - - - 
30 extended Medium - - - - - - - - - - - - - - - 
31 extended Medium - - - - - - - - - - - - - - - 
32 extended Medium - - - - - - - - - - - - - - - 
33 extended Medium - - - - - - - - - - - - - - - 
34 extended Medium - - - - - - - - - - - - - - - 
35 Short High - - - - +(5) +(5) - - - +(6) +(6) +(6) - - +(7) 
36 Short High - - +(5) - - - - - - - +(6) - - - - 
37 Short High - - - +(6) - - - - - - - - - - - 
38 Extended High - - - - - - - - - - - - - - +(6) 
39 Extended High - - +(6) +(7) - +(7) - - - +(7) +(6) - - - - 
40 Extended High - - +(7) +(6) +(7) - +(7) +(6) - +(7) +(6) +(6) +(7) - - 
+ Positive growth index observed, PCR performed on all these samples 
  These samples were confirmed by PCR and REA to be M. avium subsp. paratuberculosis 
- No growth index detected 
( ) Figures in brackets refer to the number of weeks for the growth index in positive samples to exceed 999. 
* These samples did not reach 999 even after 16 weeks incubation 
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Appendix 5:  Faecal culture results 
Scheduled samples cultured on day of collection 
Sheep  Schedule Dose         
      week 0 week 2 week 4 week 6 week 8 week 10 week 12 week 14 
1 Short Control - - - -     
2 Short Control - - - -     
3 Short Control - - - -     
7 Short Control - - - -     
8 Short Control - - - -     
4 Extended Control - - - - - - - - 
5 Extended Control - - - - - - - - 
6 Extended Control - - - - - - - - 
9 Extended Control - - - - - - - - 
10 Extended Control - - - - - - - - 
11 Short Low - - - -     
12 Short Low +* - - -     
13 Short Low - - - -     
14 Short Low - - - -     
15 Short Low - - - -     
16 Short Low - - - -     
17 extended Low - - - - - - - - 
18 extended Low - - - - - - - - 
19 extended Low - - - - - - - - 
20 extended Low - - - - - - - - 
21 extended Low - - - +* - - - - 
22 extended Low - - - - - - - - 
23 Short Medium - - - -     
24 Short Medium - - - -     
25 Short Medium - - - +*     
26 Short Medium - - - -     
27 Short Medium +(9) - - -     
28 Short Medium - - - -     
29 extended Medium - - - - - - - - 
30 extended Medium - - - - - - - - 
31 extended Medium - - - +* - - - - 
32 extended Medium - - - - - - - - 
33 extended Medium - - - - - - - - 
34 extended Medium - - - - - - - - 
35 Short High - - - -     
36 Short High - - - -     
37 Short High - - - -     
38 Extended High - - - -     
39 Extended High - - - -     
40 Extended High - - - -     
+ Positive growth index observed, PCR performed on all these samples 
  These samples were confirmed by PCR and REA to be M. avium subsp. paratuberculosis  
- No growth index detected 
( ) Figures in brackets refer to the number of weeks for the growth index in positive samples to exceed 999. 
* These samples did not reach 999 even after 16 weeks incubation 
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Appendix 5:  Faecal culture results from daily collections 
 Week sampled  1  2  3  4  5  
 Days after last dose: 6 7  1 2 3 6 7  1 2 3 6  1 2 3 6  1 2 3 7  
Sheep                                                       
                            
29 extended Medium  - -  - - - - -  - - - -  - - - -  - - - -  
30 extended Medium  - -  - +(7) - - -  - +(8) - -  - - - -  - - - -  
31 extended Medium  - -  - - - - -  - - - -  - - - -  - - - -  
32 extended Medium  - -  - - - - -  - - - -  - - - -  - - - -  
33 extended Medium  - -  +(9) - - - -  - - +(8) -  - - - -  - - - -  
34 extended Medium  - -                       
                            
38 Extended High   -  - - - - -  - - - +*  - - - -  - - - -  
39 Extended High   -  - - - - -  - - - -  +(8) - - -  - - - -  
40 Extended High   -  - - - - -  +(12) - - -  - - - -  - - - -  
                            
+ Positive growth index observed, PCR performed on all these samples. 
  These samples were confirmed by PCR and REA to be M. avium subsp. Paratuberculosis. 
- No growth index detected. 
( ) Figures in brackets refer to the number of weeks for the growth index in positive samples to exceed 999. 
* These samples did not reach 999 even after 16 weeks incubation. 
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Appendix 5:  Faecal culture results from daily collections 
                                                      
 Week sampled  6  7  8  9  10 
 Days after last dose: 2 3 6 7  1 2 3  1 2 6 7  1 2 3 6  9 10 13 14 
Sheep                                                     
                           
29 extended Medium  - - - -  - - -  - - - -  - - - -  - - - - 
30 extended Medium  - - - -  - - -  - - - -  - - - -  - - - - 
31 extended Medium  - - - -  - - -  - - - -  - - - -  - - - - 
32 extended Medium  - - - -  - - -  - - - -  - - - -  - - - - 
33 extended Medium  - - - -  - - -  - - - -  - - - -  - - - - 
34 extended Medium                         
                           
38 Extended High  - - - -  - - -  - - - -  - - - +(10)  - - - - 
39 Extended High  +* - - -  - - -  - - - -  - - - -  - - - - 
40 Extended High  - - - -  - - -  - - - -  - - - +(6)  - - - - 
                           
+ Positive growth index observed, PCR performed on all these samples 
  These samples were confirmed by PCR and REA to be M. avium subsp. Paratuberculosis. 
- No growth index detected. 
( ) Figures in brackets refer to the number of weeks for the growth index in positive samples to exceed 999. 
* These samples did not reach 999 even after 16 weeks incubation. 
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Appendix 5:  Faecal culture results from daily collections 
 Week sampled  11  12  13 
 Days after last dose: 15 16 19  21 22 23 26 27  28 29 30 
Sheep                                 
                 
29 extended Medium  - - -  - - - - -  - - - 
30 extended Medium  - - -  - - - - -  - - - 
31 extended Medium  - - -  - - - - -  - - - 
32 extended Medium  - - -  - - - - -  - - - 
33 extended Medium  - - -  - - - - -  - - - 
34 extended Medium               
                 
38 Extended High  - - -  - - - - -  - - - 
39 Extended High  - - -  - - - - -  - - - 
40 Extended High  - - -  - - - - -  - - - 
+ Positive growth index observed, PCR performed on all these samples. 
  These samples were confirmed by PCR and REA to be M. avium subsp. Paratuberculosis. 
- No growth index detected. 
( ) Figures in brackets refer to the number of weeks for the growth index in positive samples to exceed 999. 
* These samples did not reach 999 even after 16 weeks incubation. 
 
 
 
